The Delhi High Court has recently, temeperorily restrained Dr Reddy's Laboratories Ltd. from further manufacturing sunscreen ...

Dr. Reddy's Laboratories Ltd. closed 9.65% below its 52-week high of 1,404.60 rupees, which the company reached on January 8th.

Stay updated with the Dr Reddys Stock Liveblog, your one-stop destination for real-time information and analysis of a leading ...

Dr. Reddy's Laboratories Ltd. closed 8.90% below its 52-week high of 1,404.60 rupees, which the company achieved on January ...

Welcome to the Dr Reddys Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a ...

Dr Reddy’s Laboratories ( ($RDY) ) just unveiled an update. On December 12, 2025, Dr. Reddy’s Laboratories announced that the United States Food & ...

Dr Reddy’s Laboratories ( ($RDY) ) has provided an update. On December 23, 2025, Dr. Reddy’s Laboratories announced that its Board of Directors ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

SHREVEPORT, La. (KTAL/KMSS) – Dr. Reddy’s Laboratories, a global pharmaceutical company, recently closed in early 2025 due to business and financial decisions. U.S. Senator Bill Cassidy, M.D. (R-LA), ...

Dr. Reddy's Laboratories reports impressive financial results, with record-breaking sales and profitability in their recent quarter. The company shows strong growth in their India, North America, ...

Dr. Reddy's Lab is undervalued due to exaggerated concerns about Revlimid revenue decline and the underappreciated potential of new high-growth products like biosimilars and GLP-1 drugs. Despite the ...

Dr. Reddy's Laboratories has promoted Ritu Satya Sharma to Associate General Counsel – Legal Tech Ops, within 2.5 years of her joining the organisation. In her expanded role, she will support ...